Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 133rd ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CDTX	CIDARA THERAPEUTICS INC	$1.42B	-132.70%	-98.60%	-128.03%	831.10%	0.35	3.87	100.00%	-60,589.70%	-60,589.74%
ACIU	AC IMMUNE SA	$339.39M	-49.00%	-23.10%	-55.17%	-112.50%	1.55	1.33	100.00%	-174.70%	-174.09%
CVAC	CUREVAC NV	$1.20B	29.20%	25.10%	35.70%	90.50%	0.18	6.17	94.80%	37.90%	43.41%
TTRX	TURN THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	1.44	3.20	N/A	N/A	N/A
IONS	IONIS PHARMACEUTICALS INC	$12.03B	-44.30%	-8.70%	-7.89%	-4.80%	3.91	2.79	98.80%	-26.50%	-17.37%
CAMP	CAMP4 THERAPEUTICS CORP	$83.87M	N/A	-96.90%	-117.85%	-409.10%	0.28	5.60	100.00%	-1,722.10%	-1,722.08%
ERAS	ERASCA INC	$686.48M	-31.20%	-26.30%	-30.74%	-29.10%	0.20	11.04	N/A	N/A	N/A
GLUE	MONTE ROSA THERAPEUTICS INC	$790.40M	2.70%	1.70%	2.83%	4.70%	0.43	5.61	100.00%	3.90%	5.93%
ANIX	ANIXA BIOSCIENCES INC	$135.95M	-63.10%	-59.20%	-71.32%	-71.90%	0.14	8.45	N/A	N/A	N/A
HRTX	HERON THERAPEUTICS INC	$176.97M	N/A	-3.40%	-3.60%	-1.80%	-9.29	2.40	74.00%	-5.20%	-3.57%
GALT	GALECTIN THERAPEUTICS INC	$372.19M	N/A	-226.00%	-694.90%	-50.60%	-1.12	1.43	N/A	N/A	N/A
ZLAB	ZAI LAB LTD	$2.83B	-33.30%	-23.30%	-29.14%	-151.50%	0.45	3.26	63.50%	-60.30%	-59.46%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$2.92B	-161.90%	-37.80%	-60.39%	-50.70%	3.56	1.54	90.90%	-296.80%	-277.82%
MAZE	MAZE THERAPEUTICS INC	$1.44B	N/A	N/A	N/A	N/A	0.16	13.63	N/A	N/A	N/A
TNYA	TENAYA THERAPEUTICS INC	$234.69M	-93.80%	-75.70%	-90.98%	-101.70%	0.22	6.00	N/A	N/A	N/A
PVLA	PALVELLA THERAPEUTICS INC	$883.00M	-58.40%	-40.60%	-31.83%	371.60%	0.54	7.67	100.00%	50,203.80%	38,513.21%
CTMX	CYTOMX THERAPEUTICS INC	$287.82M	-553.10%	32.20%	86.63%	-811.10%	2.93	1.73	100.00%	28.20%	28.35%
MLYS	MINERALYS THERAPEUTICS INC	$2.71B	-70.40%	-65.50%	-60.84%	-126.10%	0.07	15.12	N/A	N/A	N/A
MNKD	MANNKIND CORP	$1.72B	-32.60%	7.80%	22.86%	11.40%	-8.48	2.50	74.90%	10.90%	22.71%
SION	SIONNA THERAPEUTICS INC	$1.69B	N/A	N/A	N/A	N/A	0.05	35.33	N/A	N/A	N/A
PTGX	PROTAGONIST THERAPEUTICS INC	$4.89B	8.10%	7.40%	7.88%	10.00%	0.08	16.97	100.00%	24.90%	25.71%
AMLX	AMYLYX PHARMACEUTICALS INC	$1.24B	-106.30%	-87.90%	-108.80%	-160.80%	0.09	12.05	746.80%	17,205.70%	17,255.66%
RAPT	RAPT THERAPEUTICS INC	$499.56M	-81.50%	-70.20%	-65.13%	-157.70%	0.06	21.11	N/A	N/A	N/A
CDXS	CODEXIS INC	$213.93M	-105.80%	-46.10%	-44.00%	-37.20%	1.49	5.82	77.60%	-113.70%	-94.68%
PASG	PASSAGE BIO INC	$24.41M	-103.90%	-59.90%	-95.72%	-105.40%	1.07	3.05	N/A	N/A	N/A
ATNM	ACTINIUM PHARMACEUTICALS INC	$44.61M	-129.60%	-57.30%	-73.96%	1,572.10%	1.67	9.35	N/A	N/A	N/A
IVVD	INVIVYD INC	$211.45M	-177.90%	-91.00%	-246.45%	16,623.50%	1.08	1.33	93.40%	-238.30%	-238.33%
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$11.51M	-237.50%	-189.30%	-285.68%	1,253.10%	0.31	4.26	N/A	N/A	N/A
ALGS	ALIGOS THERAPEUTICS INC	$50.75M	-123.90%	-66.80%	-53.70%	-107.30%	0.32	6.31	100.00%	-2,337.20%	-1,936.36%
KURA	KURA ONCOLOGY INC	$889.12M	-43.60%	-29.10%	-27.22%	-36.40%	1.04	8.07	100.00%	-267.50%	-261.86%
ALT	ALTIMMUNE INC	$357.44M	-62.60%	-55.30%	-48.67%	-113.70%	0.18	20.44	100.00%	-584,973.30%	-587,700.00%
RLMD	RELMADA THERAPEUTICS INC	$75.01M	-223.20%	-180.40%	-424.29%	-238.40%	0.32	4.11	N/A	N/A	N/A
GNLX	GENELUX CORP	$304.90M	-93.00%	-74.20%	-94.30%	-115.30%	0.31	4.68	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$438.44M	-60.20%	-39.70%	-51.11%	2,222.20%	0.90	4.08	97.60%	-374.80%	-374.84%
INSM	INSMED INC	$40.44B	-183.60%	-54.60%	-56.31%	-53.90%	1.50	4.63	76.50%	-264.80%	-244.81%
ABCL	ABCELLERA BIOLOGICS INC	$1.66B	-15.70%	-12.20%	-16.60%	-19.30%	0.31	10.15	100.00%	-726.20%	-911.24%
RANI	RANI THERAPEUTICS HOLDINGS INC	$126.59M	-2,437.00%	-80.50%	-628.76%	-58.10%	-9.65	0.88	100.00%	-2,483.20%	-2,093.25%
HYFT	MINDWALK HOLDINGS CORP	$86.31M	-114.30%	-61.20%	-134.12%	-119.00%	0.96	2.17	56.70%	-130.20%	-143.91%
VTGN	VISTAGEN THERAPEUTICS INC	$114.88M	-58.90%	-52.40%	-71.67%	-592.70%	0.20	6.51	100.00%	-10,579.80%	-10,578.40%
GLPG	GALAPAGOS NV	$2.09B	N/A	N/A	N/A	N/A	0.44	8.08	N/A	N/A	N/A
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$73.37M	-201.50%	-95.30%	-130.90%	-179.20%	0.84	0.83	65.70%	-3,934.40%	-3,832.35%
LEGN	LEGEND BIOTECH CORP	$5.98B	-30.90%	-19.40%	-19.89%	-40.60%	0.63	4.71	62.50%	-40.80%	-35.56%
RYTM	RHYTHM PHARMACEUTICALS INC	$7.56B	-1,884.80%	-49.70%	-66.25%	-95.90%	-20.08	2.79	89.20%	-120.50%	-103.12%
IMA	IMAGENEBIO INC	$35.03M	-24.90%	-22.50%	-25.78%	-34.00%	0.09	13.52	N/A	N/A	N/A
KROS	KEROS THERAPEUTICS INC	$618.17M	3.00%	2.70%	3.72%	61.90%	0.07	21.11	100.00%	8.10%	11.55%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$3.33B	-245.10%	-37.70%	-52.36%	-32.40%	7.96	2.46	85.30%	-87.30%	-86.93%
MCRB	SERES THERAPEUTICS INC	$140.95M	283.90%	54.90%	76.17%	59.00%	3.36	1.57	N/A	N/A	N/A
MBX	MBX BIOSCIENCES INC	$734.00M	N/A	N/A	N/A	N/A	0.05	23.31	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$220.78M	-82.80%	-63.00%	-93.02%	-74.20%	0.41	5.65	100.00%	-3,414.40%	-3,481.10%
CRBU	CARIBOU BIOSCIENCES INC	$225.36M	-71.60%	-57.00%	-85.55%	-63.50%	0.33	6.66	100.00%	-2,427.10%	-2,427.19%
LBRX	LB PHARMACEUTICALS INC	N/A	N/A	N/A	N/A	N/A	-0.09	3.78	N/A	N/A	N/A
AGEN	AGENUS INC	$126.50M	N/A	-78.00%	168.15%	-1,029.80%	-1.47	0.06	99.40%	-162.90%	-81.58%
STRO	SUTRO BIOPHARMA INC	$94.60M	-347.60%	-59.50%	-116.00%	-133.70%	-13.45	2.16	100.00%	-369.10%	-328.94%
MREO	MEREO BIOPHARMA GROUP PLC	$302.28M	-80.00%	-66.90%	-91.42%	5,084.60%	0.16	8.13	73.60%	-9,910.00%	-10,070.00%
ARVN	ARVINAS INC	$744.45M	-12.00%	-7.00%	-9.65%	-9.90%	0.49	5.64	100.00%	-19.50%	-19.45%
MNPR	MONOPAR THERAPEUTICS	$531.60M	-41.80%	-39.50%	-33.11%	-198.40%	0.03	33.94	N/A	N/A	N/A
CGON	CG ONCOLOGY INC	$3.30B	-16.70%	-16.20%	-14.96%	-19.50%	0.03	30.97	100.00%	-15,945.20%	-15,945.17%
ALMS	ALUMIS INC	$494.31M	-72.10%	-56.00%	-44.94%	-116.10%	0.26	6.05	100.00%	-1,134.50%	-1,177.16%
PROK	PROKIDNEY CORP	$900.50M	N/A	-17.10%	-20.84%	-23.90%	-0.03	11.48	100.00%	-13,752.20%	-13,599.62%
PRLD	PRELUDE THERAPEUTICS INC	$89.99M	-106.50%	-79.10%	-132.24%	-98.20%	0.52	3.68	N/A	N/A	N/A
GHRS	GH RESEARCH PLC	$888.24M	-16.70%	-16.10%	-13.28%	-54.40%	0.03	29.49	N/A	N/A	N/A
LQDA	LIQUIDIA CORP	$2.10B	-223.90%	-58.50%	-69.15%	-84.80%	15.95	2.49	69.30%	-732.20%	-640.62%
NRSN	NEUROSENSE THERAPEUTICS LTD	$27.55M	N/A	-491.20%	1,710.60%	441.30%	-4.25	0.71	N/A	N/A	N/A
MGTX	MEIRAGTX HOLDINGS PLC	$730.46M	-315.60%	-63.50%	-99.57%	-76.00%	66.13	0.88	26.60%	-415.40%	-381.52%
CLLS	CELLECTIS SA	$249.52M	-49.80%	-15.80%	-14.49%	-13.70%	2.65	1.38	100.00%	-93.00%	-42.62%
RNAC	CARTESIAN THERAPEUTICS INC	$212.05M	N/A	-10.30%	-9.65%	-20.90%	-19.78	12.34	100.00%	-124.40%	-111.27%
ONCY	ONCOLYTICS BIOTECH INC	$102.84M	-316.30%	-131.00%	-225.15%	8,462.00%	2.03	3.21	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$1.79M	-47.60%	24.00%	15.19%	-57.90%	0.09	11.04	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$15.91M	N/A	-232.70%	-437.86%	393.00%	1.51	1.52	96.50%	-1,915.30%	-1,909.79%
CNTA	CENTESSA PHARMACEUTICALS PLC	$3.34B	-56.50%	-41.80%	-46.65%	-54.70%	0.43	10.12	100.00%	-1,535.80%	-1,438.29%
SLS	SELLAS LIFE SCIENCES GROUP INC	$191.64M	-132.50%	-92.80%	-99.82%	790.00%	0.24	4.91	N/A	N/A	N/A
PSTV	PLUS THERAPEUTICS INC	$74.21M	N/A	-172.50%	-334.59%	276.00%	2.69	1.29	100.00%	-391.30%	-321.61%
LIMN	LIMINATUS PHARMA INC	$37.62M	N/A	N/A	N/A	N/A	-1.22	0.17	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$2.27B	N/A	-101.00%	-65.87%	-22.10%	-1.70	4.11	99.70%	-648.60%	-408.99%
OMER	OMEROS CORP	$498.85M	N/A	-47.70%	-96.97%	-18.90%	-1.88	0.82	N/A	N/A	N/A
TRVI	TREVI THERAPEUTICS INC	$1.42B	-41.40%	-38.20%	-23.78%	-68.40%	0.05	22.43	N/A	N/A	N/A
NTLA	INTELLIA THERAPEUTICS INC	$1.31B	-58.70%	-46.30%	-60.20%	-51.60%	0.26	4.90	100.00%	-1,154.10%	-1,154.10%
ATAI	ATAI LIFE SCIENCES NV	$1.25B	-85.60%	-64.40%	-71.26%	-83.40%	0.32	4.02	100.00%	-5,171.20%	-5,050.97%
MPLT	MAPLIGHT THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.08	4.89	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$26.42M	N/A	-103.70%	298.06%	201.40%	-2.02	0.34	-225.80%	105,099.60%	105,099.65%
NVAX	NOVAVAX INC	$1.36B	-142.30%	28.70%	47.97%	117.00%	34.52	2.36	88.30%	39.20%	42.13%
HURA	TUHURA BIOSCIENCES INC	$127.62M	-277.90%	-172.70%	-137.59%	-3,839.60%	0.78	0.83	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$1.78B	-147.60%	-110.30%	-137.81%	-130.20%	0.17	9.01	16.30%	-5,534.20%	-5,530.60%
LENZ	LENZ THERAPEUTICS INC	$847.68M	-25.60%	-24.40%	-25.08%	-29.60%	0.05	20.54	100.00%	-1,048.00%	-1,037.94%
CVM	CEL SCI CORP	$48.79M	-259.40%	-107.20%	-167.96%	-105.40%	1.90	0.47	N/A	N/A	N/A
GERN	GERON CORP	$803.90M	-32.00%	-16.30%	-12.13%	-10.20%	1.14	7.87	97.80%	-53.50%	-36.21%
ALDX	ALDEYRA THERAPEUTICS INC	$303.67M	-73.60%	-50.60%	-87.88%	-115.80%	0.54	2.86	N/A	N/A	N/A
CURX	CURANEX PHARMACEUTICALS INC	$18.81M	N/A	N/A	N/A	N/A	1.58	9.37	N/A	N/A	N/A
VTYX	VENTYX BIOSCIENCES INC	$608.26M	-48.90%	-44.90%	-54.46%	-52.80%	0.10	19.12	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$5.10M	-675.50%	-175.70%	-223.84%	-428.90%	1.40	2.27	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$963.93M	N/A	-94.40%	-138.80%	-37.00%	-1.57	2.23	87.20%	-186.50%	-138.77%
FATE	FATE THERAPEUTICS INC	$155.70M	-55.70%	-40.20%	-50.01%	-39.90%	0.42	8.04	100.00%	-2,025.10%	-2,025.05%
AUTL	AUTOLUS THERAPEUTICS PLC	$412.52M	-56.20%	-29.60%	-36.84%	-33.00%	1.08	8.43	-79.70%	-760.90%	-803.46%
BEAM	BEAM THERAPEUTICS INC	$2.53B	-43.20%	-31.10%	-32.75%	-42.50%	0.33	6.75	100.00%	-661.30%	-661.31%
NRXP	NRX PHARMACEUTICALS INC	$61.09M	N/A	-658.10%	94.89%	181.50%	-1.14	0.11	N/A	N/A	N/A
ENTO	ENTERO THERAPEUTICS INC	$6.75M	N/A	-20.00%	-11.59%	-11.00%	-4.71	2.81	N/A	N/A	N/A
IVA	INVENTIVA SA	$411.35M	N/A	-284.90%	-93.27%	-121.40%	-21.09	2.96	100.00%	-1,767.30%	-638.55%
CADL	CANDEL THERAPEUTICS INC	$295.34M	-41.00%	-26.80%	-22.70%	381.80%	0.18	7.04	N/A	N/A	N/A
XLO	XILIO THERAPEUTICS INC	$41.31M	-399.20%	-58.70%	-69.80%	263.80%	17.93	2.32	100.00%	-374.80%	-374.79%
DNA	GINKGO BIOWORKS HOLDINGS INC	$760.33M	-63.10%	-32.70%	-40.11%	-41.90%	1.00	4.88	80.00%	-198.80%	-198.98%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Mimedx Group (NASDAQ:MDXG)

Mimedx Group (NASDAQ:MDXG) is the #1 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Mimedx Group (NASDAQ:MDXG) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: B.

Mimedx Group (NASDAQ:MDXG) has a Due Diligence Score of 48, which is 25 points higher than the biotech industry average of 23.

MDXG passed 15 out of 33 due diligence checks and has strong fundamentals. Mimedx Group has seen its stock return 11.68% over the past year, overperforming other biotech stocks by 32 percentage points.

Mimedx Group has an average 1 year price target of $12.00, an upside of 56.86% from Mimedx Group's current stock price of $7.65.

Mimedx Group stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Mimedx Group, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the #2 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Incyte (NASDAQ:INCY) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: B.

Incyte (NASDAQ:INCY) has a Due Diligence Score of 60, which is 37 points higher than the biotech industry average of 23.

INCY passed 19 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock return 26.12% over the past year, overperforming other biotech stocks by 46 percentage points.

Incyte has an average 1 year price target of $88.75, a downside of -5.06% from Incyte's current stock price of $93.48.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 12 analysts covering Incyte, 50% have issued a Strong Buy rating, 0% have issued a Buy, 41.67% have issued a hold, while 8.33% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #3 top biotech stock out of 624 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 36, which is 13 points higher than the biotech industry average of 23.

TBPH passed 11 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.91% over the past year, overperforming other biotech stocks by 98 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 75.08% from Theravance Biopharma's current stock price of $14.66.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 10.57%, which is 8 percentage points higher than the biotech industry average of 2.67%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.32%, which is the same as the biotech industry average of 2.67%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

3. Bio Techne (NASDAQ:TECH)

Bio Techne (NASDAQ:TECH) has an annual dividend yield of 0.51%, which is -2 percentage points lower than the biotech industry average of 2.67%. Bio Techne's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Bio Techne's dividend has not shown consistent growth over the last 10 years.

Bio Techne's dividend payout ratio of 68.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.7% in the last day, and up 2.96% over the last week. Cabaletta Bio was the among the top gainers in the biotechnology industry, gaining 46.15% yesterday.

Cabaletta Bio shares are trading higher after Cantor Fitzgerald maintained its overweight on the stock and raised Its price target from $15 to $30.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -11.08% in the past year. It has overperformed other stocks in the biotech industry by 9 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 78.95% in the past year. It has overperformed other stocks in the biotech industry by 99 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 57, which is 43 points higher than the biotech industry average of 14. It passed 4 out of 7 valuation due diligence checks.

Incyte's stock has gained 26.12% in the past year. It has overperformed other stocks in the biotech industry by 46 percentage points.

Are biotech stocks a good buy now?

58.9% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 59.57% over the next year.

2.89% of biotech stocks have a Zen Rating of A (Strong Buy), 4.96% of biotech stocks are rated B (Buy), 44.21% are rated C (Hold), 33.47% are rated D (Sell), and 14.46% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -9.18x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Mimedx Group (NASDAQ:MDXG)

2. Incyte (NASDAQ:INCY)

3. Theravance Biopharma (NASDAQ:TBPH)

1. Dominari Holdings (NASDAQ:DOMH)

2. Royalty Pharma (NASDAQ:RPRX)

3. Bio Techne (NASDAQ:TECH)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.